FDA Approved: TOBRAMYCIN INHALATION SOLUTION PAK — Supplemental Application (Genericus, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Tobramycin Inhalation Solution PAK from Genericus, Inc., enabling its marketing as a supplemental approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• TOBRAMYCIN INHALATION SOLUTION PAK (TOBRAMYCIN)

Snippet

SUPPL AP for TOBRAMYCIN INHALATION SOLUTION PAK (TOBRAMYCIN)